Avidity Biosciences
RNA
#1825
Rank
C$15.04 B
Marketcap
C$99.84
Share price
0.28%
Change (1 day)
123.24%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$15.04 Billion

As of December 2025 Avidity Biosciences has a market cap of C$15.04 Billion. This makes Avidity Biosciences the world's 1825th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025C$15.04 B191.81%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Avidity Biosciences was reported to be:

C$15.04 Billion
by Nasdaq info icon info icon
C$15.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
C$8.70 B-42.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.13 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.04 B-79.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.02 B-73.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.16 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$15.08 B 0.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$197.66 B 1,213.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$136.77 B 809.21%๐Ÿ‡ฌ๐Ÿ‡ง UK